CAP Today: Innovations in Immune Profiling for Clinical Research
In this webinar we heard leading experts discuss how they are leveraging flow cytometry to expand and improve the immune profiles of every precious sample in clinical research trials.
Presenters:
- Caroline Roe, MLI
- Sasidhar Vemula, PhD
- Vinicius Motta, PhD
PRESENTERS
Cutting Edge Cytometry and Clinical Trials: A Case Study
Caroline Roe, MLI
Managing Director
Vanderbilt University
Roe shares her approach to high-parameter immune monitoring panel design, as well as the planning and execution of clinical correlative studies. She discusses the utility of patient-specific analysis tools for high-dimensional cytometry data and inferring biological significance from research assays.
Method Validation Studies Using the Maxpar® Direct™ Immune Profiling Assay™
Sasidhar Vemula, PhD
Lead Scientist
Labcorp Drug Development
Vanderbilt University
Vemula details the validation process for two Maxpar panels offered by Labcorp: the Maxpar Direct Immune Profiling Assay and the Maxpar Basic Human T Cell Immuno-Oncology Panel Set.
Efficient, High-Content Immune Profiling with CyTOF® XT and Maxpar Direct Immune Profiling Assay
Vinicius Motta, PhD
Field Applications Specialist
Motta describes how fully automated flow cytometry with CyTOF XT™ combined with the deep immune profiling provided by the Maxpar Direct Immune Profiling Assay standardizes and simplifies a crucial application for clinical research.
Submit the form below to watch the videos.
Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.